SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
Long-term continuous OGSIVEO treatment for up to 4 years was associated with…
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION Platform at the European Society of Medical Oncology Annual Congress
October 19, 2025 10:00 ET | Source: AVACTA GROUP PLC Median progression…
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH),…
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2025 16:24 ET | Source: Pyxis Oncology BOSTON, Sept. 30,…
Geri Care hosts 3rd Geri Care Geriatric Conclave & 2nd Asian Geriatric Oncology Society (AGOS) Conference in Bengaluru
BENGALURU, India, Sept. 17, 2025 /PRNewswire/ -- Geri Care, India's pioneer in…
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer
Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of…
Adagenes ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
September 05, 2025 09:55 ET | Source: Adagene Inc. SAN DIEGO and…
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc.,…
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1…
Everhope Oncology Launches First Cancer Daycare Centre in Gurugram — Revolutionizing Cancer Care with Compassion, Precision and Convenience
Everhope Oncology takes the anxiety out of cancer treatment — with zero…
